In this video, Drs. David Teachey and Stephen Hunger, investigators at the Cancer Center at CHOP, talk about a 2025 New England Journal of Medicine study that "changes the way that we treat children with leukemia across the globe". Following the results of a Phase 3 clinical trial co-led by Drs. Teachey and Hunger, most children in the United States newly diagnosed with B-cell acute lymphoblastic leukemia (B-ALL) can now receive an immunotherapy called blinatumomab as part of their standard trea

Join us on September 29 for our annual #ParkwayRun presented by Citadel. With your help, we can fund vital pediatric cancer research, advance treatment options and offer new hope to patients and their families. Register or donate today at parkway.chop.edu. #ForBreakthroughs | Cancer Center at CHOP

Chemotherapy Side Effects

Progression After R-CHOP: What Next? | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways

Quimioterapia r-Chop: o que esperar - Sua saúde 2026

How to Minimize Prednisone Side Effects | Dr. Megan

Which SSRI Antidepressants Have the Least Side Effects? 4 Options - GoodRx